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Abstract 
Pregnant Sprague–Dawley rats were exposed to ethylbenzene (EB; 0, 250, or 1000 ppm) and 
methylethylketone (MEK; 0, 1000, or 3000 ppm), alone and in combination, by inhalation, for 
6 h/day, during days 6–20 of gestation. Maternal toxicity, evidenced by decreased in body 
weight gain and food consumption, tended to be greater after simultaneous exposures to the 
high concentrations of 1000 ppm EB and 3000 ppm MEK, when compared to the treatments 
with individual compounds. No significant increase in embryo/fetal lethality or incidence of 
malformations and variations was observed in any of the treatment groups. Fetal body weight 
was significantly reduced after individual treatment with 1000 ppm EB or 3000 ppm MEK, 
and in the combined groups. There was no evidence of interaction between EB and MEK in 
causing developmental toxicity. 
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1. Introduction 
Solvents are commonly found in combinations in commercially available products (e.g., 
paints), and are used as mixtures in most manufacturing and processing units. A number of 
them have been shown to elicit developmental toxic effects in laboratory animals, but there 
are few data on their effects when encountered in combination (Nelson, 1994). 
Ethylbenzene (EB) is an intermediate for the production of styrene and is a component of 
technical xylene, which is used as an industrial solvent in paints and lacquers, and in the 
rubber and chemical manufacturing industry. EB is also present in automotive and aviation 
fuels, and crude oils (WHO, 1996). There have been several studies investigating the 
developmental toxicity of inhaled EB in experimental animals. Hardin et al. (1981) exposed 
Sprague–Dawley rats and New Zealand white rabbits to 100 or 1000 ppm EB for 7 h/day, on 
gestation days (GD) 1–19 and 1–24, respectively. 
An increased incidence of a skeletal variation (supernumerary ribs) was noted in rats at 1000 
ppm EB, in the presence of maternal toxicity (i.e., increased liver, kidney and spleen weights). 
In a recent study, Sprague–Dawley rats were exposed to 100, 500, 1000 or 2000 ppm EB, for 
6 h/ day, from GD 6 through GD 20. Maternal toxicity, evidenced by decreased food 
consumption and weight gain, occurred at 1000 and 2000 ppm. The fetal body weight was 
reduced at the two highest concentrations. Exposure to 2000 ppm also caused an increased 
incidence of fetuses with skeletal variations (Saillenfait et al., 2003). In contrast, post-
implantation loss and fetal skeletal retardation were reported following exposure of rats to 
600, 1200 and 2400 mg/m3 (i.e., 140, 280, 550 ppm, respectively), for 24 h/day, from GD 7 
to GD 15 (Ungvary and Tatrai, 1985). Skeletal malformations (not specified), extra ribs, and 
anomalies of the uropoietic apparatus were also observed at the high concentration. In rabbits, 
exposure to 1000 mg/m3 of EB (i.e., 230 ppm) for 24 h/day on GD 7–20 resulted in 
spontaneous abortions. 
Methylethylketone (MEK) is a widely used solvent for lacquers, adhesives, and cleaning 
materials prior to electroplating. Little information is available in the published literature on 
the potential developmental toxicity of MEK. A low incidence of malformations (acaudia, 
imperforate anus, brachygnatia) was reported in fetuses from Sprague– Dawley rats exposed 
for 7 h/day to 3000 ppm MEK, from day 6 to 15 of gestation (Schwetz et al., 1974). There 
was also an increase in soft tissue alterations (dilated ureter and subcutaneous edema) at 3000 
ppm, and in skeletal alterations (delayed ossification and extra ribs) at 1000 and 3000 ppm. 
No maternal toxicity was noted (i.e., serum SGPT, body and liver weight). Deacon et al. 
(1981) exposed Sprague– Dawley rats to 400, 1000, or 3000 ppm MEK, for 7 h/day, on GD 
6–15. Increased occurrence of skeletal variations (mainly delayed ossification of skull bone) 
was observed at 3000 ppm, in the presence of maternal toxicity (i.e., decreased body weight 
gain and increased water consumption). In CD1 mice, signs of developmental toxicity were 
seen after exposure to 3000 ppm of MEK during major organogenesis (e.g., decrease in fetal 
body weight, several malformed fetuses) (Schwetz et al., 1991). 
The placental transfer of EB and MEK in human pregnancy has been demonstrated (Dowty et 
al., 1976). 
The metabolic conversion of EB proceeds mainly through oxidation of the side chain 
(Ensgtro¨m, 1984; Ensgtro ¨m et al., 1985). Both EB andMEK can affect the expression of 
particular P450 isozymes (Dietz et al., 1981; Raunio et al., 1990; Imaoka and Funae, 1991; 
Sequeira et al., 1992, 1994; Backes et al., 1993; Yuan et al., 1995, 1997; Bergeron et al., 
1999). Metabolic interactions between EB and MEK with other industrial chemicals have 
been shown in rodents and humans (Angerer and Lehnert, 1979; Ensgtro¨m et al., 1984; 
Freundt et al., 1989; Skowron et al., 2001). Thus, combined inhalation exposure to MEK and 
meta-xylene or MEK and toluene resulted in inhibited oxidation of the side chain of the 
aromatic hydrocarbons (Liira et al., 1988, 1991; Uaki et al., 1995). MEK is known to enhance 
the toxicity of some other organic solvents, possibly through changes in their metabolism, 
e.g., the neurotoxicity of n-hexane and the hepatotoxicity of chlorinated hydrocarbons in rats. 
Ethylbenzene and methylethylketone are ubiquitous environmental contaminants and have 
been detected in indoor air (Tang et al., 2000). They are among the most commonly used 
organic solvents, and are found together in several commercial and industrial applications 
(e.g., painting, printing, degreasing). The possibility exists that the workers and the general 
population may be simultaneously exposed to those two chemicals. Thus, this study was 
designed to examine the developmental toxic effects of EB and MEK in combination 
following inhalation exposure of rats during the embryonic and fetal period. Inhalation was 
used since it is a likely route of human exposure. To better characterize its developmental 
toxic effects and to aid in establishing exposure levels for the mixture study, a concentration-
response study was conducted with MEK alone, which results are included in this report. The 
influence of simultaneous exposures to EB and MEK on common biological parameters was 
also examined in non-pregnant rats, using the same conditions of treatment. 
 
2. Materials and methods 
 
2.1. Chemicals 
Ethylbenzene (EB, CAS 100-41-4, P99.5% pure) and methylethylketone (MEK, CAS 78-93-
3, P99.5% pure) were obtained from Fluka Chemie AG (Buchs, Switzerland). 
 
2.2. Animals 
After two weeks of acclimatization, nulliparous female (180–200 g) Sprague–Dawley rats 
supplied by IFFA CREDO Breeding Laboratories (Saint-Germain-sur-l’Arbresle, France) 
were housed overnight with adult males (one male: two or three females) from the same strain 
and supplier. The day that vaginal smears were found to be sperm-positive was considered 
day 0 of gestation. Mated females were randomly assigned to the treatment groups using a 
randomization system stratified by body weight on GD 0. Mated females were housed singly 
in clear polycarbonate cages with stainless-steel wire lids and corn cob granules as bedding in 
rooms maintained at 21 ± 2 C, a relative humidity of 50 ± 5%, and a 12-h light– dark 
photocycle. For exposures, the females were transferred to stainlesssteel wire mesh exposure 
cages, and the cages were moved into the chambers. After each exposure, the animals 
returned to their original cages and ‘‘home’’ rooms. Food pellets (UAR Alimentation 
Villemoisson, France) and filtered tap water were available ad libitum except during 
exposures. 
 
2.3. Experimental design 
Two developmental toxicity experiments have been carried out: In the first experiment, the 
effects of MEK alone were investigated. Groups of 24–25 bred rats (19–23 pregnant) were 
exposed to 0 (control), 1000, 2000, 4000, or 6000 ppm of MEK, 6 h/day, on days 6 through 
20 of gestation. 
In the second experiment, the combined effects of EB and MEK were investigated. Groups of 
18–19 bred rats (15–19 pregnant) were exposed to vapours of EB or MEK, separately or in 
combination, 6 h/day, on days 6 through 20 of gestation. There were 9 experimental groups: 
Control; 250 or 1000 ppm EB; 1000 or 3000 ppm MEK; or mixtures of 250 ppm EB + 1000 
ppm MEK, 250 ppm EB + 3000 ppm MEK, 1000 ppm EB + 1000 ppm MEK, or 1000 ppm 
EB + 3000 ppm MEK. Concentrations were selected based on the results from the first 
experiment for MEK, and on a previous study conducted in the same laboratory for EB 
(Saillenfait et al., 2003). No maternal and developmental effects were expected at 250 ppm 
EB or 1000 ppm MEK, and mild toxicity at 1000 ppm EB or 3000 ppm MEK. Control 
animals were exposed concurrently to filtered room air in an adjacent chamber identical to 
those of the treatment groups. 
 
2.4. Generation of test atmospheres 
Exposures were conducted in 200 L glass/stainless-steel inhalation chambers with dynamic 
and adjustable laminar air flow (5–10 m3/h). In order to prevent any leakage of the test 
atmospheres, the chambers were maintained at a negative pressure of no more than 3 mm 
water. The chamber temperature was set at 23 ± 0.8 C and the relative humidity at 51 ± 5%. 
Chemical vapours were generated by passing an additional airflow rates through the fritted 
disk of a heated bubbler containing either of the test chemical. Under these conditions the 
vaporized compounds were carried out into the main air inlet pipe of the exposure chambers. 
 
2.5. Atmosphere sampling and analysis 
Concentrations of EB and MEK were monitored continuously with a gas chromatograph 
(Shimadzu GC14B model and Perkin Elmer autosystem XL) equipped with a flame ionization 
detector and an automatic gassampling valve. The column temperature was maintained at 150 
C. In addition, the exposure levels were determined once during the 6-h exposure period by 
collecting atmosphere samples through glass tubes packed with activated charcoal. EB and 
MEK were then desorbed with carbon disulfide and analyzed on a Shimadzu GC-8A gas 
chromatograph, using toluene and n-propyl acetate as internal standards, respectively. 
Samples were chromatographed on a 2 m long column packed with PEG 20 M. Column and 
injector were maintained at 75 and 250°C, respectively. Because the concentration determined 
by analyses was essentially the same as the target concentration, it will be referred to the 
target concentration in this paper. 
 
2.6. Maternal and fetal evaluations 
Food consumption was measured for the intervals GD 6–13 and 13– 21. Maternal body 
weights were recorded on GD 0, 6, 13, and 21. On GD 21, the females were killed with an 
intrapulmonary injection of T61 (Hoechst, Frankfurt, Germany). The uterus was then 
removed and weighed. The number of corpora lutea, implantation sites, resorptions, and dead 
and live fetuses were recorded. Uteri, which had no visible implantation sites, were stained 
with ammonium sulphide (10%) to detect very early resorptions (Salewski, 1964). Live 
fetuses were weighed, sexed, and examined for external anomalies including those of the oral 
cavity. Half of the live fetuses from each litter was preserved in Bouin’s solution and 
examined for internal soft tissue changes (Wilson, 1965; Barrow and Taylor, 1969). The other 
half was fixed in ethanol (70%), eviscerated, and then processed for skeletal staining with 
alizarin red S for subsequent skeletal examination (Staples and Schnell, 1964). 
 
2.7. Short-term toxicity study on EB and MEK mixture 
Because of the paucity of data on EB and MEK combinations, additional toxic and metabolic 
endpoints were examined to help characterize possible interaction between the two solvents. 
Complementary data were also needed to better understand the factors that may determine the 
effects of the mixture. 
In a separate experiment, groups of 6 non-pregnant female rats were exposed to EB and MEK, 
alone and in combination, for 15 days, under the same experimental conditions as the 
pregnant rats. At the end of the first and last exposures, the rats were placed in individual 
metabolic cages in which they had free access to food and water, and urines were collected at 
+4 C over a 16-h period. After the last urine collection, the animals were euthanized by 
bleeding from the abdominal aorta under anaesthesia. The liver and the kidney were removed, 
weighed and prepared for histologic evaluation: They were fixed in 10% neutral buffered 
formalin prior to paraffin embedding. Sections were cut at 3 lm and stained with 
haematoxylin and eosin (Ruehl-Fehlert et al., 2003). 
Biochemical parameters were measured in the samples of serum and urine using an automated 
analyzer (Cobas Mira Plus, Roche Diagnostics) and reagent kits (Roche Diagnostics, ABX 
Diagnostics). Serum endpoints included: aspartate aminotransferase (ASAT), alanine 
aminotransferase (ALAT), urea, creatinine. Urine evaluations included: volume, creatinine, 
proteins, and enzyme activities of c-glutamyl transferase (GGT), alkaline phosphatase (ALP), 
and lactate deshydrogenase (LDH). 
In addition, aliquots of urine were frozen at -20°C until determination of mandelic acid 
according to a modification of the HPLC methods of Kivisto et al. (1993) and Ogata and 
Sugihara (1978). 
 
2.8. Statistical analysis 
Whenever possible, the data were presented as mean ± SD. The litter was used as the basis for 
analysis of fetal variables. 
 
2.8.1. Developmental toxicity study on MEK alone 
The number of implantation sites and live fetuses and various body weights were analyzed by 
one-way analysis of variance, followed by Dunnett’s test if differences were found. The 
frequency of post-implantation loss, dead fetuses, resorptions and alterations among litters 
was evaluated by using the Kruskal–Wallis test followed by the Mann–Whitney test where 
appropriate. Rates of pregnancy, and proportions of fetuses and litters with any 
malformations, or external, visceral, skeletal, or any variations in the treated groups were 
compared with those of the control group by the Fisher’s test. Where applicable, least-squares 
analysis was carried out. The reported level of statistical significance was p < 0.05. 
 
2.8.2. Studies on EB and MEK mixture 
A large number of data sets did not show homogeneity of variance (Bartlett’s test). Therefore, 
all data were analyzed using a non-parametric analysis of variance (Kruskal–Wallis test), 
followed by the Mann–Whitney test for multiple comparisons among the treatment groups, 
when significance was indicated (p < 0.05). Interactions between EB and MEK were analyzed 
by two-way analysis of variance on ranks. Additivity was assumed when this analysis showed 
no significant interaction between the two solvents (p > 0.1). 
 
3. Results 
 
3.1. Developmental toxicity study on MEK alone 
No test dam died (Table 1). Maternal weight gain was decreased during the first half of 
exposure at 4000 ppm, and during the whole exposure period at 6000 ppm (Table 1). The 
corrected weight gain was significantly depressed at 4000 and 6000 ppm. Food consumption 
was significantly reduced throughout the exposure period at 4000 and 6000 ppm (Table 2). 
The number of implantations and of live fetuses, and the incidence of non-live implants and 
resorptions were comparable across groups (Table 3). There was a concentration-related 
decrease in fetal body weight (all, males, and females), which achieved statistical significance 
at 2000 ppm and above. The 4% decrease at 2000 ppm reached 19–20% at 6000 ppm. 
Malformations occurred in single instances at the two highest concentrations of MEK (Table 
4). At 4000 ppm, they included one fetus with unilateral anophthalmia, one fetus with 
diaphragmatic hernia, and one fetus with anal atresia, thread-like tail, and various 
malformations of the vertebral column (fused thoracic archs and centra, sacral and caudal 
vertebrae absent). Anal atresia associated with absence of tail was also present in one fetus 
from the 6000 ppm MEK group. No variation was observed externally. Visceral variations 
(mainly dilated ureter) were distributed across all groups, with no indication of any 
treatmentrelated effect. The incidences of two skeletal variations (i.e., delayed ossification of 
sternebrae and rudimentary cervical ribs) were elevated at 4000 and 6000 ppm (Table 5) 
However, there were no significant changes in the incidence of total skeletal variations or all 
variations. 
 
Table 1 
Body weight gain of dams inhaling methylethylketone on days 6–20 of gestation 
 
 
 
 
 
 
 
 
 
Table 2 
Food consumption of dams inhaling methylethylketone on days 6–20 of gestation 
 
 
Table 3 
Reproductive parameters in rats inhaling methylethylketone on days 6–20 of gestation 
 
 
 
 
3.2. Developmental toxicity study on EB and MEK mixture 
 
3.2.1. Maternal effects 
Exposure to EB or MEK alone did not cause any significant changes in maternal body weight 
gain compared with the control, although a slight decrease was observed during GD 6–13 in 
rats inhaling 1000 ppm EB (Table 6). In contrast, a significant reduction occurred on GD 6–
13 after co-exposure to 250 ppm EB and 3000 ppm MEK, and during the entire treatment 
period after combined exposure to 1000 ppm EB with 1000 or 3000 ppm MEK. Corrected 
weight gain was significantly less than control in groups receiving 1000 ppm EB or 3000 ppm 
MEK, alone or in combination with either levels of the other solvent. 
Food consumption was significantly lower than control on GD 13–21 in the low concentration 
mixture group (250 ppm EB and 1000 ppm MEK), and throughout exposure in the three other 
mixture groups (Table 7). When EB and MEK were given alone, food consumption was only 
significantly different from control at 1000 ppm EB, on GD 6–13. Statistical analysis 
indicated a significant interaction for maternal weight gain on GD 6–13 (p < 0.01) and GD 6–
21 (p < 0.06), and for maternal food consumption on GD 6–13 (p < 0.1). 
 
3.2.2. Reproductive and fetal effects 
EB and MEK, alone or in combination, have no effect on the average number of implantations 
and live fetuses, and in the incidence of non-live implants and resorptions (Table 8). The body 
weight of the fetuses (all, males, females) was significantly lower than control after exposure 
to the high concentrations of EB or MEK alone (1000 and 3000 ppm, respectively), or to 
either mixtures. No statisti- cally significant interaction was found, and when the decreases 
associated with exposure to mixtures of EB and MEK were compared with the decreases 
observed after exposure to individual solvents, additivity was indicated. Thus, they amounted 
8% at 1000 ppm EB, 6–7% at 3000 ppm MEK, and 18–19% following co-exposure to 1000 
ppm EB with 3000 ppm MEK. Few malformations were seen, which were limited to the 1000 
ppm EB group (visceral) and to the four combination groups (external, visceral and/or 
skeletal) (Table 9). Each finding occurred in no more than one or two fetuses per group. 
These malformations could not be conclusively attributed to treatment, since the incidences of 
specific or total malformations were not significantly different from control, and did not show 
a concentration-related pattern. Common external, visceral, and skeletal variations (primarily 
14th ribs and/or incomplete ossification of thoracic vertebral centra) were seen, with no 
significant differences in their individual or total incidences between the control and treated 
groups (Table 10). 
 
Table 4 
Observations in fetuses of rats inhaling methylethylketone on days 6–20 of gestation (summary) 
 
 
Table 5 
Incidences of specific skeletal variations in fetuses of rats inhaling methylethylketone on days 6–20 of gestationa 
 
 
Table 6 
Body weight gain of dams inhaling ethylbenzene and methylethylketone, alone or in combinations, on days 6–20 of gestation 
Treatment 
 
 
 
 
 
 
 
 
Table 7 
Food consumption of dams inhaling ethylbenzene and methylethylketone, alone or in combinations, on days 6–20 of gestation 
 
 
Table 8 
Reproductive parameters in rats inhaling ethylbenzene and methylethylketone, alone or in combinations, on days 6–20 of 
gestation 
 
 
 
 
3.3. Short-term toxicity study on EB and MEK mixture 
 
3.3.1. Serum and urine biochemistry 
In non-pregnant rats, repeated co-exposures to the high concentration mixture (1000 ppm EB 
and 3000 ppm MEK) resulted in a 2- to 2.6-fold increase in the urinary excretion of ALP (p < 
0.05), LDH, creatinine (p < 0.01), and proteins, relative to control. The urinary volume was 
also significantly elevated (22.2 ml versus 6.1 ml in control, p < 0.01), as were serum ALAT, 
ASAT (Table 11). 3.3.2. Liver and kidney weights and histopathology Compared with 
control, both absolute liver weight and liver to body weight ratios were significantly elevated 
in animals treated with 250 ppm EB, 1000 ppm EB, or 3000 ppm MEK, alone, or with either 
mixtures (Fig. 1). The magnitude of increase was slightly higher in rats coexposed to 1000 
ppm EB and 3000 ppm MEK, compared to the changes associated with individual EB and 
MEK (30%, 13–16%, and 65–70%, for 1000 ppm EB, 3000 ppm MEK, and combined 1000 
ppm EB and 3000 ppm MEK, respectively). However, no statistically significant interaction 
was found. 
 
 
 
 
 
 
Table 9 
Types and incidences of malformations in fetuses of rats inhaling ethylbenzene and methylethylketone, alone or in 
combinations, on days 6–20 of 
gestationa 
 
 
There was no significant change in the absolute and relative kidney weight whatever 
treatment group. Histological evaluation of liver and kidney revealed no pathological effects 
attributable to individual or combined solvents exposures. Periportal hepatocyte hypertrophy 
with clear cytoplasm, compared with centrilobular hepatocytes, was commonly noted. This 
observation was minimally present in the control group and appeared moderate to marked in 
the high concentrations groups. Findings of this nature are in favour of an adaptative response 
without pathological signification (Greaves, 2000). 
 
3.3.3. Urine mandelic acid levels 
The excretion of mandelic acid was 2- to 5-fold higher after 15 exposures than after one 
exposure to 1000 ppm EB, alone or in combination. After repeated treatments, the urinary 
level of mandelic acid was significantly greater after co-exposure to 1000 ppm EB and 3000 
ppm MEK, compared with 1000 ppm EB alone (Fig. 2). A significant EB by MEK interaction 
was seen (p < 0.01). No other significant difference was noted in mixtures when compared to 
animals treated with EB alone, although mandelic acid tended to decrease with increasing 
concentration of MEK, after one exposure to EB at either concentration or after repeated 
exposures to 250 ppm EB (p < 0.1). 
 
4. Discussion 
The main purpose of this investigation was to evaluate the potential for interaction between 
the two solvents, EB and MEK, on the prenatal development in the rat. At the levels used in 
our study, EB and MEK alone caused no or limited maternal effects, while evidence of 
maternal toxicity was observed after concurrent exposures to increasing concentrations EB 
and MEK, as reflected by decreases in maternal weight gain, corrected body weight, and/or 
food consumption. Interactions between EB and MEK were demonstrated for several 
maternal endpoints, including weight gain and food consumption on GD 6–13. Their 
decreases were greater for combined EB and MEK than the summation of individual 
responses, thereby the mixture produced effects seemingly greater than additive (Nelson, 
1994; Haghdoost et al., 1997). Nevertheless, a minimal level (1000 ppm EB and/or 3000 ppm 
MEK) was considered necessary for enhancement since no change was seen in animals 
exposed to the lowest concentration of mixture (i.e., 250 ppm EB with 1000 ppm MEK). The 
developmental toxic effects of the mixture were consistent with the effects of the individual 
solvents. Thus, exposure to EB and MEK either alone or in combination resulted in fetal 
toxicity, as evidenced by decreased fetal body weight, and there was no increase in 
embryolethality and in the incidence of fetal malformations. The magnitude of fetal weight 
decreases induced by co-administration of EB with MEK was not greater than the additive 
responses of the individual chemicals. Thus, combination effects vary with different endpoints 
within the same experimental design: The two solvents working synergically on several 
maternal parameters showed no significant interaction on the developmental endpoints 
assessed. It is noticeable that the interactions were mostly evident at the highest 
concentrations of mixture. In a risk assessment situation, the default assumption of response 
additivity may not underestimate maternal and developmental toxic effects caused by 
concurrent inhalation exposures to low levels of EB and MEK (ATSDR, 2004). However, 
responses may vary with the treatment conditions (e.g., period, route). 
 
Table 10 
Types and incidences of variations malformations in fetuses of rats inhaling ethylbenzene and methylethylketone, alone or in 
combinations on days 6–20 
of gestationa 
 
 
 
 
 
 
 
Table 11 
Serum chemistry of non-pregnant rats inhaling ethylbenzene and methylethylketone, alone or in combinations 
 
 
Fig. 1. Liver-body weight ratios. Significantly different from control group (air), *p < 0.05 and **p < 0.01, respectively. Significantly 
different from EB 
alone at the same concentration, __p < 0.01. Significantly different from MEK alone at the same concentration, __p < 0.01. 
 
 
Fig. 2. Urinary excretion of mandelic acid. Significantly different from ethylbenzene alone at the same concentration, *p < 0.05. 
 
 
 
 
Our developmental toxicity findings agree with previous results in rats given EB alone under 
similar exposure conditions (e.g., length of daily exposure) (Hardin et al., 1981; Saillenfait et 
al., 2003). Schwetz et al. (1974) have reported a low incidence of anal atresia associated with 
tail defects after exposure of rats to 3000 ppm MEK, 7 h/day, on GD 6–15. Sporadic cases of 
these malformations were observed in our dose-range finding study at 4000 and 6000 ppm 
MEK in the presence of maternal toxicity, and after co-exposure to 250 ppm EB with 1000 
ppm MEK. However, their occurrence remained rare, with no clear dose-response 
relationship. 
Similarly the developmental toxicity study, additional evaluation of the effects of the mixture 
on some toxic and metabolic endpoints in adult female animals revealed minimal interaction 
between EB and MEK at the low concentrations levels. Only prolonged exposure to the 
mixture at high concentrations led to more consistent changes. Thus, individual treatment to 
EB or MEK resulted in a significant increase in the liver weight of non-pregnant rats. The 
absence of accompanying histopathologic lesions or increases in the activities of the serum 
enzymes of hepatocellular injury suggested an adaptative response, rather than a toxic effect. 
However, the highest combination (1000 ppm EB and 3000 ppm MEK) resulted in leakage of 
hepatic enzymes. In addition, the increase in liver weight was more pronounced than after 
individual treatments (i.e., not simple summation of the individual solvent effects), suggesting 
more than additive effects at these concentrations. The classical biochemical markers of 
kidney damage (e.g., serum creatinine and urea) were unaffected, except from slight changes 
in few urinary parameters (mainly increase in the urinary volume) in the high EB/MEK 
exposure group. The absence of gross and histopathological changes in the kidney of 
treatment groups indicated that EB and MEK, individually or in combination, have minimal 
nephrotoxic effects. These results are in accordance with previous inhalation studies. Fisher 
344 rats exposed to 382 or 782 ppm EB for four weeks had increased liver weights, but 
normal histopathology, and urine and serum biochemistry (Cragg et al., 1989). Concentration-
related increases in weights of liver and kidney, in the absence of microscopic lesions, were 
also observed in F344 rat exposed to 250–1000 ppm EB for 13 weeks (NTP, 1992). Male 
Wistar rats exposed up to 600 ppm EB for 16 weeks showed no increase in serum ALAT, nor 
liver cell necrosis. Nevertheless, proliferation of liver smooth endoplastic reticulum was seen, 
consistent with the stimulation of mixed function oxidase and other enzyme activities 
(Elovaara et al., 1985). Increased liver weight was also reported in rats inhaling 800 ppm 
MEK for four weeks (Toftgard et al., 1981) or 5000 ppm for 13 weeks (Cavender et al., 
1983). 
In addition to the dose level, our metabolic findings show that combined exposure to solvents 
can produce complex results, depending on the number of exposures. Mandelic acid results 
from oxidations of the side chain of EB, and is one of its major urinary metabolites following 
inhalation exposure in rats and humans (Ensgtro¨m et al., 1984, 1985). In our study, co-
exposure with MEK was associated with changes in EB metabolism. Thus, MEK tended to 
reduce the urinary levels of mandelic acid in a concentration-related manner after acute or 
repeated co-treatments with the low concentration of EB (250 ppm), or after acute co-
treatments with the high EB concentration (1000 ppm). In vitro experiments using human 
liver microsomes have shown that the initial step of EB metabolism is predominantly 
metabolised by CYP 2E1 (Sams et al., 2004). MEK is metabolized by reductive, and mostly 
by oxidative pathways. This latter biotransformation process probably involves the 
microsomal monooxygenase system (DiVincenzo et al., 1976; Dietz et al., 1981). Under these 
exposure patterns, it is possible that MEK may compete with EB for the same enzymatic site 
of metabolism. These results are consistent with previous reports on combinations of MEK 
and aromatic hydrocarbons. Thus, simultaneous inhalation exposure of rats to toluene (50 or 
100 ppm) and MEK (200 and 400 ppm) resulted in a reduction in the urinary excretion of 
hippuric acid, an oxidative metabolite of toluene (Uaki et al., 1995). The oxidation of the side 
chain of meta-xylene, producing methyl hippuric acid, was also inhibited in the presence of 
MEK in rats and humans (Liira et al., 1988, 1991). In contrast to the other co-exposure 
regimens, repeated exposures to the highest combination of EB and MEK led to a steep 
increase in the excretion of mandelic acid. EB and MEK are known to enhance liver 
microsomal enzyme activities, including cytochromes P450 (Elovaara et al., 1984, 1985; 
Brady et al., 1989; Raunio et al., 1990; Liira et al., 1991; Nedelcheva, 1996; Sequeira et al., 
1992, 1994; Backes et al., 1993; Raymond and Plaa, 1995; Yuan et al., 1995, 1997; Bergeron 
et al., 1999; Serron et al., 2000). Probable increase in hepatic metabolic capability induced by 
continued and high level exposures to MEK and EB, may have modified EB metabolism and 
kinetics (e.g., enhanced metabolite formation). The differences in EB excretion profile 
suggest that metabolic, and possibly toxic, interactions may change during the course of 
maternal exposure. The timing of interaction may be important in regard to the critical periods 
of the development susceptibility. 
In the current study, simple analyses were applied to examine the effects of combined EB and 
MEK, i.e., twoway analysis of variance and arithmetic sum of the effects of individual 
compounds (i.e., effect summation). More thorough analyses would be necessary to further 
estimate and characterize the greater-than-additive interactions observed in several cases, in 
particular, a more extensive dose-response evaluation would be required (Silva et al., 2002). 
Several approaches have been proposed to properly detect interactions of chemicals in 
mixture, including physiologically based toxicokinetic-pharmacodynamic modeling, response 
surface analysis, and response-addition (i.e., independent action) and dose-addition methods 
(Groten et al., 2004; Yang et al., 2004;Monosson, 2005). Several statistical designs have also 
been developed, such as fractional or full factorial design (Groten et al., 1996). Thus, the 
concentration- addition model has proved to be useful to predict the mixture effects of 
estrogenic or antiandrogenic chemicals (Payne et al., 2001; Silva et al., 2002; Birkhoj et al., 
2004). From the literature available, only few in vivo developmental toxicity studies have 
used these tools to analyze mixture data, non-additive effects were reported, however 
(Narotsky et al., 1995; Nelson et al., 1999). 
In conclusion, results from this study provide no evidence of developmental toxicity 
interaction of inhaled EB and MEK in rats, and suggest that the default assumption of 
additivity may be appropriate to estimate the maternal and developmental effects of EB and 
MEK following concurrent inhalation exposures at low concentration levels. However, the 
possibility that other treatment conditions might result in a different conclusion cannot be 
excluded. Thus, this study also highlights the importance of the experimental design when 
studying combined effects of chemicals. 
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